Ochre Bio

Ochre Bio is a biotechnology company dedicated to revolutionizing the discovery and development of liver therapies. They leverage a unique combination of computational and multi-omic technologies to deeply phenotype human liver samples and models. This allows them to causally map genes to cells, histology, and clinical data, providing a more comprehensive understanding of liver disease. Ochre's innovative approach not only accelerates the development of therapies but also increases the likelihood of clinical success.

Based in Oxford, UK, with additional locations in New York City, NY, and Taipei City, Taiwan, Ochre Bio has established strong partnerships with leading pharmaceutical companies such as GSK and Boehringer Ingelheim. They are committed to tackling the global challenge of chronic liver disease, which affects millions of patients worldwide. By developing advanced RNA medicines, Ochre aims to provide new treatment options for those suffering from this debilitating condition and improve their quality of life.

Ochre Bio offers flexible work arrangements, including remote work options for some roles. For example, the "Principal Computational Biologist" position is based in Oxford Science Park but allows remote work for UK-based candidates with site visits. The "(Senior) Computational Biologist" position also offers remote work but requires UK-based candidates with site visits. These positions indicate a willingness for flexibility, although specific details for other roles are not explicitly stated.

Ochre Bio is a biotechnology company focused on revolutionizing liver disease treatment through the development of advanced RNA therapies. They are driven by a deep understanding of human liver biology and leverage a unique platform that combines computational and multi-omic technologies to identify and validate therapeutic targets. Ochre's mission is to address the high unmet need for effective treatments for patients suffering from chronic liver disease, aiming to ultimately improve patient outcomes and change the future of liver disease treatment.

Ochre Bio emphasizes a culture of ambitious innovation, rapid learning, and collaborative support. They embrace failure as an opportunity to learn and encourage employees to think big and take risks. They value transparency and communication, fostering a supportive environment where everyone feels comfortable sharing ideas and helping each other succeed.

Ochre Bio is committed to fostering a diverse, equitable, and inclusive workplace. They prioritize building a team that reflects the diversity of their patient population and believe that a wide range of perspectives and experiences leads to better scientific outcomes. They actively promote equal opportunities for all employees, regardless of background, race, gender, sexual orientation, or disability, and encourage open communication and collaboration to create a welcoming and supportive environment for everyone.